Advertisement

Ads Placeholder
Loading...

Alterity Therapeutics Limited

ATHE•NASDAQ
Healthcare
Biotechnology
$3.56
$-0.07(-2.00%)
U.S. Market is Open • 12:53

Alterity Therapeutics Limited (ATHE) Stock Overview

Explore Alterity Therapeutics Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap32.2M
P/E Ratio-6.07
EPS (TTM)$-0.58
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$2.90
3 Months$0.78
1 Year Target$5.66

ATHE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alterity Therapeutics Limited (ATHE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.07 and a market capitalization of 32.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.22%
5-Day Change
15.06%
1-Month Change
4.57%
3-Month Change
12.51%
6-Month Change
-16.35%
Year-to-Date (YTD) Change
12.51%
1-Year Change
21.34%
3-Year Change
29.28%
5-Year Change
-75.48%
All-Time (Max) Change
-99.48%

Contact Information

https://alteritytherapeutics.com
61 3 9349 4906
460 Bourke Street, Melbourne, VIC, 3000

Company Facts

100 Employees
IPO DateSep 29, 2003
CountryAU
Actively Trading

Frequently Asked Questions